Stay updated on Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page.

Latest updates to the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0, indicating a version metadata change rather than a content update.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page now displays a new system revision label (v3.4.2) and removes older notices (v3.4.1). This update appears to be a UI/system change and does not modify study data or visible content.SummaryDifference0.4%

- Check67 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status was added, and the page revision was updated to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check74 days agoChange DetectedAdded a Show glossary link and new results-status fields (Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted) while removing older timestamps and the No FEAR Act data field, and updated the revision from v3.3.4 to v3.4.0.SummaryDifference0.3%

- Check88 days agoChange DetectedPage revision label updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page.